Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-25-014154
Filing Date
2025-03-20
Accepted
2025-03-20 17:29:09
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A itci-20241231.htm   iXBRL 10-K/A 905252
2 EX-31.3 itci-20241231xex313.htm EX-31.3 3521
3 EX-31.4 itci-20241231xex314.htm EX-31.4 3563
8 itci-20241231_g1.jpg GRAPHIC 151593
  Complete submission text file 0001628280-25-014154.txt   1705625

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20241231.xsd EX-101.SCH 2705
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20241231_def.xml EX-101.DEF 3085
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20241231_lab.xml EX-101.LAB 3580
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20241231_pre.xml EX-101.PRE 2176
21 EXTRACTED XBRL INSTANCE DOCUMENT itci-20241231_htm.xml XML 16821
Mailing Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36274 | Film No.: 25757866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)